Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03906071 |
|---|---|
| Brief Title: | Phase 3 Study of Sitravatinib Plus Nivolumab vs Docetaxel in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (SAPPHIRE) |
| First Submitted : | April 4, 2019 |
| First Submitted that Met QC Criteria : | April 4, 2019 |
| First Posted : | April 8, 2019 |
| Last Update Submitted that Met QC Criteria : | March 10, 2021 |
| Last Update Posted : | March 12, 2021 |